跳至主要内容
临床试验/EUCTR2020-001198-55-DK
EUCTR2020-001198-55-DK进行中(未招募)1 期

Proactive Prophylaxis with Azithromycin and Hydroxychloroquine Patients Hospitalized with COVID - ProPAC-COVID

Chronic Obstructive Pulmonary Disease Trial Network (COP:TRIN)0 个研究点目标入组 117 人开始时间: 2020年3月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
117

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Patients admitted to a danish emergency department or department of respiratory medicine or internal medicine
  • - Age >18 år
  • - Hospitalized <48 hours
  • - Positive COVID-19 test/diagnosis during hospitalization
  • - fertile women must present a negative pregnancy test
  • - signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 36
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 190

排除标准

  • - If the patient uses >5 LO2/min on time of recruitment
  • - Known intolerance/allergy to azithromcyin or hydroxychloroquine
  • - Liver diseases other than amoebiasis
  • - Severe gastrointestinal, neurological and hematological disorders
  • -eGFR <45 ml/min/1.73m2
  • - Severe cardiac conduction disorders or (risk of) prolonged QT interval
  • - Myasthenia gravis
  • - Neurogenic hearing loss
  • - Psoriasis
  • - Retinopathy
  • - Maculopathy
  • - Visual fiels changes
  • - Breastfeeding
  • - Hypersensitivity to quinine or 4-aminoquinoderivates
  • -Uses Digoxin
  • - Shortage of glucose-6-phosphatedehydrogenase
  • - Porphyria
  • - Hypoglycemia
  • - Severe mental illness which significantly complicates cooperation
  • - Severe linguistic problems that significantly complicates cooperation
  • - Concomitant administration of sickle alkaloids

研究者

发起方
Chronic Obstructive Pulmonary Disease Trial Network (COP:TRIN)

相似试验